MERCK Kommanditgesellschaft auf Aktien Share Price Other OTC
Equities
MKKGY
US5893392093
Pharmaceuticals
Sales 2024 * | 21.26B 22.82B 1,902B | Sales 2025 * | 22.52B 24.17B 2,015B | Capitalization | 65.35B 70.14B 5,847B |
---|---|---|---|---|---|
Net income 2024 * | 2.96B 3.17B 264B | Net income 2025 * | 3.49B 3.74B 312B | EV / Sales 2024 * | 3.39 x |
Net Debt 2024 * | 6.72B 7.21B 601B | Net Debt 2025 * | 4.9B 5.26B 438B | EV / Sales 2025 * | 3.12 x |
P/E ratio 2024 * |
22
x | P/E ratio 2025 * |
18.7
x | Employees | - |
Yield 2024 * |
1.53% | Yield 2025 * |
1.61% | Free-Float | 29.71% |
Latest transcript on MERCK Kommanditgesellschaft auf Aktien
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 13/20/13 | |
Marcus Kuhnert
DFI | Director of Finance/CFO | 56 | 01/14/01 |
Director of Finance/CFO | 53 | 26/19/26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 75 | 09/14/09 | |
Chairman | 67 | 26/19/26 | |
Jürgen Glaser
BRD | Director/Board Member | 61 | 01/12/01 |
1st Jan change | Capi. | |
---|---|---|
+12.55% | 9.06B | |
-12.75% | 4.96B | |
+42.38% | 4.47B | |
+5.23% | 3.9B | |
+21.52% | 2.41B | |
-19.05% | 2.41B | |
-28.72% | 2.23B | |
+11.13% | 2.02B | |
+4.60% | 1.65B |